CureVac
CureVac is a Germany-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $132.1M
Employees: 501-1,000
Industries / Tags:
Detailed CureVac Information
Geographic Data
Address: Friedrich-Miescher-Str. 15
City: Tubingen
State: baden-württemberg
Zip: 72076
Country: DE
Financial Info
Stage:
post ipo equity
Raised Last:
$450M
Raised Total:$2B
Social
Metrics
973,499Website Global Rank
34,843Website Monthly Traffic
Twitter Followers
Description
CureVac is a Germany-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
CureVac went public on 8/14/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/14/2020
IPO Valuation:
$3B
Ticker Symbol:
CVAC
IPO Price:
$16/share
Amount Raised:
$213M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2022 | Frame Cancer Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
